Acadia Healthcare

ACHC

Market cap $1.49B

FRANKLIN, Tenn.--(BUSINESS WIRE)---- $ACHC--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced an update to its professional and general liability (“PLGL”) reserves, following its annual, third-party actuarial review of anticipated PLGL costs. This update reflects higher expected expenses associated primarily with patient-related litigation. As a result, the Company now expects full-year 2025 Adjusted EBITDA in the range of $601 million to $611 million, compared to.

Acadia Healthcare Company, Inc. ( ACHC ) UBS Global Healthcare Conference 2025 November 11, 2025 2:45 PM EST Company Participants Christopher Hunter - CEO & Director Todd Young - Chief Financial Officer Conference Call Participants Joseph Overman - UBS Investment Bank, Research Division Presentation Joseph Overman UBS Investment Bank, Research Division Hey, everyone. I'm Joseph Overman, I'm on the health care managed care and facilities team here at UBS.

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in a fireside chat at the UBS Global Healthcare Conference, November 9 - 12, 2025, in Palm Beach Gardens, Florida. In connection with the conference, there will be an online webcast of the Company's presentation available on the Company's website starting at 1:45 p.m. Central Time / 2:45 p.m. Eastern Time on Tuesday, November 11, 2025. The live webcast of the presen.

ACHC beats Q3 estimates on stronger patient volumes, but rising costs and lower guidance remain concerning.

Acadia Healthcare Company, Inc. ( ACHC ) Q3 2025 Earnings Call November 6, 2025 9:00 AM EST Company Participants Brian Farley - Executive VP, General Counsel & Secretary Christopher Hunter - CEO & Director Todd Young - Chief Financial Officer Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Pito Chickering - Deutsche Bank AG, Research Division Brian Tanquilut - Jefferies LLC, Research Division Benjamin Mayo - Leerink Partners LLC, Research Division Ryan Langston - TD Cowen, Research Division Jason Cassorla - Guggenheim Securities, LLC, Research Division Andrew Mok - Barclays Bank PLC, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Joanna Gajuk - BofA Securities, Research Division Presentation Operator Hello, and thank you for standing by. My name is Lacey, and I will be your conference operator today.

Acadia Healthcare Company, Inc. faces shrinking profits, reputational challenges, and operational headwinds, but remains the largest stand-alone behavioral healthcare provider in the U.S. ACHC's 2025 guidance was lowered, margins are under pressure, and shares have dropped sharply amid ongoing investigations and management turnover. Activist investor Engine Capital is pushing for operational improvements, cost rationalization, and governance reforms, offering a potential catalyst for turnaround.

ACHC, FWRD and CENX have been added to the Zacks Rank #5 (Strong Sell) List on Nov. 6, 2025.

Acadia Healthcare (ACHC) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $0.91 per share a year ago.

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Results Revenue totaled $851.6 million, an increase of 4.4% over the third quarter of 2024 Same facility revenue increased 3.7% compared with the third quarter of 2024, including an increase in revenue per patient day of 2.3% and an increase in patient days of 1.3% Same facility admission.

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.